JFNIX
Price
$68.15
Change
+$0.16 (+0.24%)
Updated
Dec 20 closing price
RYHAX
Price
$34.63
Change
+$0.36 (+1.05%)
Updated
Dec 20 closing price
Ad is loading...

JFNIX vs RYHAX

Header iconJFNIX vs RYHAX Comparison
Open Charts JFNIX vs RYHAXBanner chart's image
Janus Henderson Global Life Sciences I
Price$68.15
Change+$0.16 (+0.24%)
VolumeN/A
CapitalizationN/A
Rydex Health Care H
Price$34.63
Change+$0.36 (+1.05%)
VolumeN/A
CapitalizationN/A
JFNIX vs RYHAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JFNIX vs. RYHAX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and RYHAX is a Buy.

FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 5.25B vs. RYHAX (23.2M). JFNIX pays higher dividends than RYHAX: JFNIX (0.15) vs RYHAX (0.00). JFNIX was incepted earlier than RYHAX: JFNIX (15 years) vs RYHAX (27 years). RYHAX is a more actively managed with annual turnover of: 268.00 vs. JFNIX (34.00). RYHAX has a lower initial minimum investment than JFNIX: RYHAX (2500) vs JFNIX (1000000). RYHAX annual gain was more profitable for investors over the last year : 2.85 vs. JFNIX (1.54). JFNIX return over 5 years is better than : 14.61 vs. RYHAX (13.06).
JFNIXRYHAXJFNIX / RYHAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years27 years-
Gain YTD-1.2480.844-148%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.25B23.2M22,642%
Annual Yield % from dividends0.150.00-
Returns for 1 year1.542.8554%
Returns for 3 years0.12-6.13-2%
Returns for 5 years14.6113.06112%
Returns for 10 years37.9017.11221%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WTLVX13.350.13
+1.02%
Allspring Large Company Value R6
PGBHX46.690.44
+0.95%
Principal Blue Chip R6
FEICX34.950.32
+0.92%
Fidelity Advisor Equity Income C
STMSX23.140.15
+0.65%
SEI Tax-Managed Small/Mid Cap F (SIMT)
WCMLX12.950.08
+0.62%
WCM Small Cap Growth Institutional